Clinical trial NCT05359744: Multi-level Molecular Profiling of Peak Performance in Endurance Sports
Official title: A Pilot-study on Multi-level Molecular Profiling of Peak Performance in Endurance Sports
Study type: INTERVENTIONAL
Overall status: UNKNOWN
Phase: NA
Conditions: Exercise
Exercise Test
Physical Fitness
Healthy
Keywords: Exercise Test
Autophagy
Multi-omic
Fitness level
Lead sponsor: Paracelsus Medical University
Sponsor class: OTHER
Collaborators: name: Department of Psychiatry University of Bonn
First posted: 2022-05-04
Enrollment: 80
Sex: ALL
Minimum age (years): 18
Maximum age (years): 40
Standard ages: ADULT
Accepts healthy volunteers: yes
Allocation: NON_RANDOMIZED
Intervention model: PARALLEL
Intervention model description: 3 groups undergoing intervention, 1 control group
Primary purpose: BASIC_SCIENCE

Brief summary: Physical activity triggers complex molecular responses, including changes in immune-, stress-, and metabolic pathways. For example, autophagy is essential for energy and cellular homeostasis through protein catabolism, and dysregulation results in compromised proteostasis, reduced exercise performance, and excessive secretion of signaling molecules and inflammatory proteins. However, previous research has been limited by the extend of molecules measured and biological processes covered. A better understanding of these processes through multi-omic analysis can improve knowledge of molecular changes in response to exercise. The main purpose of the investigators study is to analyze the effects of acute exercise in correlation to autophagy and other signaling cascades. Specifically, the investigators plan to perform multi-level molecular profiling in a cohort of healthy male elite cyclists and male and female recreational athletes, before, during, and after a bicycle ergometer test. The results will be compared to a control cohort without intervention.

Detailed description: This is a non-randomized controlled trial performed at the Paracelsus Medical University, Salzburg, Austria. The study will recruit 80 healthy men and women. Subjects who meet the inclusion criteria will be allocated to four arms (n = 20 in all groups): 1. elite cyclists, 2. male recreational athletes, 3. female recreational athletes, 4. male control group.

After overnight fasting and medical check-up, groups 1-3 will undergo a bicycle ergometer-based exercise protocol designed to span low (aerobic) to severe (anaerobic) domains of exercise. The protocol consists of a 15 min aerobic warm-up phase followed by a ramp-bicycle ergometer protocol.

During exercise, performance-relevant data will be continuously monitored. Venous blood specimens will be collected before exercise (baseline), at the end of the warm-up as well as 2 min, 10 min, and 30 min in recovery.

Eligibility criteria: Inclusion Criteria:

* All arms: ability to give written informed consent
* Arms 1- 3: inconspicuous medical examination (medical history, resting ECG, echocardiography)
* Elite athletes (arm1, cyclists): maximum oxygen uptake \> 65 ml/kg/KG
* Elite athletes (arm1, cyclists): participation in cycling competitions on a regular basis
* Recreational athletes (arms 2 and 3): maximum oxygen uptake \< 65 ml/kg/KG for male subjects and \< 55 ml/kg/KG for female subjects

Exclusion Criteria:

* All arms: unable to communicate adequately by language
* All arms: regular use of prescription drugs other than thyroxine or antihistamines
* All arms: alcohol consumption as equivalent doses averaging more than 40 g of pure alcohol per day
* All arms: use of illicit drugs
* All arms: known diseases of the cardiovascular system
* All arms: arterial hypertension over 160/90 mmHg at rest
* All arms: known pulmonary diseases, especially bronchial asthma
* All arms: surgery less than 4-6 months ago.
* All arms: abnormalities in the medical examination (medical history, resting ECG, echocardiography)
* Arms 1-3: orthopaedic diseases that preclude maximum exercise on a bicycle ergometer
* Elite athletes (arm1, cyclists): maximum oxygen uptake \< 65 ml/kg/KG
* Recreational athletes (arms 2 and 3): maximum oxygen uptake \> 65 ml/kg/KG for male subjects and \> 55 ml/kg/KG for female subjects
* Arm 3: positive urine ß-HCG

Primary outcomes:
measure: Proteomics and autophagy processes
timeFrame: Before the exercise test (baseline), at the end of the 15 minute warm-up phase and 2 minutes, 10 minutes and 30 minutes after termination of the exercise test.
Secondary outcomes:
measure: Salivary cortisol levels
timeFrame: Before the exercise test (baseline), at the end of the 15 minute warm-up phase and 2 minutes, 10 minutes and 30 minutes after termination of the exercise test.
measure: Proteome patterns
timeFrame: Before the exercise test (baseline), at the end of the 15 minute warm-up phase and 2 minutes, 10 minutes and 30 minutes after termination of the exercise test.
measure: Metabolic processes
timeFrame: Before the exercise test (baseline), at the end of the 15 minute warm-up phase and 2 minutes, 10 minutes and 30 minutes after termination of the exercise test.
measure: Lipid profiling
timeFrame: Before the exercise test (baseline), at the end of the 15 minute warm-up phase and 2 minutes, 10 minutes and 30 minutes after termination of the exercise test.
measure: Phosphoproteome patterns
timeFrame: Before the exercise test (baseline), at the end of the 15 minute warm-up phase and 2 minutes, 10 minutes and 30 minutes after termination of the exercise test.
measure: Ubiquitinome patterns
timeFrame: Before the exercise test (baseline), at the end of the 15 minute warm-up phase and 2 minutes, 10 minutes and 30 minutes after termination of the exercise test.
measure: Epigenetic patterns
timeFrame: Before the exercise test (baseline), at the end of the 15 minute warm-up phase and 2 minutes, 10 minutes and 30 minutes after termination of the exercise test.
measure: Exosomal protein patterns
timeFrame: Before the exercise test (baseline), at the end of the 15 minute warm-up phase and 2 minutes, 10 minutes and 30 minutes after termination of the exercise test.
Other outcomes:
Locations:
city: Salzburg
country: Austria
facility: Paracelsus Medical University
Study officials:
affiliation: Department of Obstetrics and Gynecology, University Hospital Salzburg, Austria
name: Jens Stepan, MD, PhD
role: PRINCIPAL_INVESTIGATOR
References:
citation: Hasin Y, Seldin M, Lusis A. Multi-omics approaches to disease. Genome Biol. 2017 May 5;18(1):83. doi: 10.1186/s13059-017-1215-1.
citation: Nicora G, Vitali F, Dagliati A, Geifman N, Bellazzi R. Integrated Multi-Omics Analyses in Oncology: A Review of Machine Learning Methods and Tools. Front Oncol. 2020 Jun 30;10:1030. doi: 10.3389/fonc.2020.01030. eCollection 2020.
citation: Contrepois K, Wu S, Moneghetti KJ, Hornburg D, Ahadi S, Tsai MS, Metwally AA, Wei E, Lee-McMullen B, Quijada JV, Chen S, Christle JW, Ellenberger M, Balliu B, Taylor S, Durrant MG, Knowles DA, Choudhry H, Ashland M, Bahmani A, Enslen B, Amsallem M, Kobayashi Y, Avina M, Perelman D, Schussler-Fiorenza Rose SM, Zhou W, Ashley EA, Montgomery SB, Chaib H, Haddad F, Snyder MP. Molecular Choreography of Acute Exercise. Cell. 2020 May 28;181(5):1112-1130.e16. doi: 10.1016/j.cell.2020.04.043.
citation: Mukherjee K, Edgett BA, Burrows HW, Castro C, Griffin JL, Schwertani AG, Gurd BJ, Funk CD. Whole blood transcriptomics and urinary metabolomics to define adaptive biochemical pathways of high-intensity exercise in 50-60 year old masters athletes. PLoS One. 2014 Mar 18;9(3):e92031. doi: 10.1371/journal.pone.0092031. eCollection 2014.
citation: De Pauw K, Roelands B, Cheung SS, de Geus B, Rietjens G, Meeusen R. Guidelines to classify subject groups in sport-science research. Int J Sports Physiol Perform. 2013 Mar;8(2):111-22. doi: 10.1123/ijspp.8.2.111.
citation: Martin DT, McLean B, Trewin C, Lee H, Victor J, Hahn AG. Physiological characteristics of nationally competitive female road cyclists and demands of competition. Sports Med. 2001;31(7):469-77. doi: 10.2165/00007256-200131070-00002.
citation: Hoffman NJ. Omics and Exercise: Global Approaches for Mapping Exercise Biological Networks. Cold Spring Harb Perspect Med. 2017 Oct 3;7(10):a029884. doi: 10.1101/cshperspect.a029884.